COMMUNIQUÉS West-GlobeNewswire

Nicox : Point d’activité et résumé financier du deuxième trimestre 2019
17/07/2019
Communiqué de presse Nicox : Point d’activité et résumé financier du deuxième trimestre 2019 Recrutement terminé dans l’étude clinique de phase 2 sur le NCX 470 pour le glaucome et l’hypertension oculaire. Premiers [...]
Genkyotex Announces FDA Approval of Phase 2 Investigator-Initiated Trial with GKT831 in IPF
17/07/2019
Study expands potential clinical indications for lead compound Trial fully funded via a grant from the United States National Institutes of Health ARCHAMPS, France, July 17, 2019 (GLOBE NEWSWIRE) -- Genkyotex (Euronext [...]
Genkyotex annonce l'approbation par la FDA de l'essai de Phase 2 avec le GKT831 dans la fibrose pulmonaire
17/07/2019
Cette étude élargit les indications cliniques potentielles pour ce composé phare Essai financé par une subvention des National Institutes of Health aux États-Unis ARCHAMPS, France, 17 juill. 2019 (GLOBE NEWSWIRE) -- [...]
First Publication from OSE Immunotherapeutics on the Role of SIRPα in the Induction and Maintenance of Immune Tolerance in the American Journal of Transplantation
17/07/2019
Findings show the role of the SIRPα/CD47 axis in the maintenance of acquired immune tolerance Highlights the differentiated mechanism of action of OSE's innovative myeloid checkpoint inhibitor BI 765063 (OSE-172), a [...]
Repligen Corporation Announces Pricing of Public Offerings of $120 million of Common Stock and $250 million of 0.375% Convertible Senior Notes due 2024
17/07/2019
WALTHAM, Mass., July 17, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) (“Repligen”) today announced the pricing of concurrent underwritten public offerings of 1,380,000 shares of its common stock (the “ [...]
Novelion Therapeutics Announces Dismissal of Whitefort Capital Petition
17/07/2019
VANCOUVER, British Columbia, July 16, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]
Immuron Announces Proposed Public Offering of ADSs
16/07/2019
MELBOURNE, Australia, July 16, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for [...]
Cytori Will Become Plus Therapeutics, Inc.
16/07/2019
Plus Therapeutics Reflects A New Focus On Developing Innovative Drugs AUSTIN, Texas, July 16, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX) (the “company”) announced yesterday a new direction and [...]
BeyondSpring Announces Proposed Public Offering of Ordinary Shares
16/07/2019
NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a global clinical stage biopharmaceutical company focused on the development and commercialization of [...]
Wright Medical Group N.V. to Host Second Quarter 2019 Earnings Conference Call
16/07/2019
Wednesday, August 7, 2019 at 3:30 p.m. Central / 4:30 p.m. Eastern AMSTERDAM, The Netherlands, July 16, 2019 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) today announced that it will host a conference [...]
Eyenovia, Inc. Announces Underwriters’ Full Exercise of Over-Allotment Option in Public Offering
16/07/2019
NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print [...]
Forty Seven, Inc. Announces Proposed Underwritten Public Offering of Common Stock
16/07/2019
MENLO PARK, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- Forty Seven, Inc. (Nasdaq: FTSV), a clinical stage immuno-oncology company, today announced that it has commenced an underwritten public offering of $75,000,000 of [...]
ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 21, 2019
16/07/2019
LYON, France and CAMBRIDGE, Mass., July 16, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP) announced that its 2019 Annual General Meeting was held in Paris on Friday, June 21, 2019. At the [...]
ERYTECH Pharma présente le résultat des votes de l’Assemblée Générale Mixte du 21 juin 2019
16/07/2019
LYON, France, 16 juill. 2019 (GLOBE NEWSWIRE) -- L’Assemblée Générale Mixte des actionnaires de la Société ERYTECH Pharma (Euronext : ERYP – Nasdaq : ERYP) s’est réunie à Paris le vendredi 21 juin 2019. L’Assemblée [...]
Health Care Administrators Association (HCAA) Announces Inaugural Event: TPA Connect 2019
16/07/2019
New Baltimore event set to bring TPAs together for an intimate educational and networking conference focused on “Forging New Bonds Across Self-Funding” ST. LOUIS, Mo., July 16, 2019 (GLOBE NEWSWIRE) -- The Health Care [...]
Disclosure of received notification
16/07/2019
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 16 July 2019 – 8:00pm CEST Disclosure of received notification Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major [...]
North American Partners in Anesthesia (NAPA) expands Anesthesia Services in Chicago, welcomes Anesthesia Clinicians at Little Company of Mary Hospital
16/07/2019
MELVILLE, N.Y., July 16, 2019 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA) , one of the leading single-specialty anesthesia and perioperative management companies in the US, announces that it is [...]
Apollo Managed Care Attains URAC Health Content Provider Accreditation
16/07/2019
Designation demonstrates the highest level of commitment to quality healthcare SACRAMENTO, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- Apollo Managed Care, Inc. (Apollo), an organization offering medical review criteria [...]
Generex Biotechnology Announces Investor Conference Call Scheduled for July 25, 2019
16/07/2019
Management to Provide Details on Generex Biotechnology Up-list and 1:1 Stock Dividend MIRAMAR, Fla., July 16, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) today announced [...]

Pages